In line with these findings, Douget and others have developed a positive allosteric modulator at P2X7, which potentiates the activity of anti PD-1 in lung cancer, leading to tumor regression and the creation of a strong immunological memory (Douguet et al., 2021) (Figure 2B). Here, P2RX7 is linked to lung cancer.